Share Issue/Capital Change • Mar 1, 2021
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 6948Q
Asimilar Group PLC
01 March 2021
1 March 2021
ASIMILAR GROUP PLC ('ASIMILAR' OR 'THE COMPANY')
Dev Clever Subscription
Further to the announcement of 25 February 2021, Asimilar Group plc (AIM: ASLR), the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), confirms that its wholly owned subsidiary, Intrinsic Capital Jersey Limited ("ICJL"), has completed the assignment of its right to subscribe for up to 30 million ordinary shares in Dev Clever Holdings plc ("Dev Clever") at 10 pence per share ("Subscription Rights") to Sitius Limited ("Sitius") for a consideration of £3 million. ICJL has agreed to use the cash consideration arising from the assignment to Sitius to subscribe in full for the remaining 30 million ordinary shares in Dev Clever under the remaining Subscription Rights held by ICJL. The subscription is subject to the publication by Dev Clever of a prospectus approved by the FCA by a revised back stop date of 31 March 2021 or such later date agreed by ICJL and the Company.
-ends-
For further information please contact:
| Asimilar Group plc | ||||
| John Taylor, Non-Executive Chairman | via Buchanan | |||
| Cairn Financial Advisers LLP | ||||
| Sandy Jamieson / Liam Murray | Tel: +44 20 7213 0880 | |||
| Peterhouse Capital Limited | ||||
| Duncan Vasey / Lucy Williams | Tel: + 44 20 7220 9797 | |||
| Buchanan Communications Limited | ||||
| Richard Oldworth / Chris Lane | Tel: +44 (0) 20 7466 5000 | |||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
FURUARARAAUORAR
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.